Market Cap 419.62M
Revenue (ttm) 160.01M
Net Income (ttm) -546.38M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -341.47%
Debt to Equity Ratio 0.00
Volume 2,764,500
Avg Vol 6,868,588
Day's Range N/A - N/A
Shares Out 310.83M
Stochastic %K 21%
Beta 2.31
Analysts Sell
Price Target $2.21

Company Profile

Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing solutions to resolve genetically complex problems. The company provides sequencing systems; consumable products, including single molecule real-time (SMRT) technology; long-read sequencing; and various reagent kits designed for specific workflow, such as preparation kit to convert DNA into SMRTbell double-stranded DNA library formats, including molecular biology reagents, such as ligase, buffers, and exonuclea...

Industry: Medical Devices
Sector: Healthcare
Phone: 650 521 8000
Fax: 650 618 2699
Address:
1305 O’Brien Drive, Menlo Park, United States
janed102
janed102 Sep. 5 at 11:49 PM
$PACB Weekend reading for you... https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2026.1861975/full
0 · Reply
FinanceCorp
FinanceCorp Sep. 4 at 8:19 PM
$PACB closed out my near term trade from this week , kept a fairly large position in place
1 · Reply
FinanceCorp
FinanceCorp Sep. 4 at 8:03 PM
$PACB took profit . We closed at 1.40 last week . To close five cents under that for a penny trade is a lot, if it would’ve regained that 1.40 range then we were good to go. The volume is just way too low . Possible further downside and a break of support levels at 1.28
0 · Reply
FinanceCorp
FinanceCorp Sep. 4 at 7:53 PM
$PACB give me 1.37 and I’ll relax , if not have to take profit
0 · Reply
selftaught
selftaught Sep. 4 at 3:33 PM
$PACB out for a quick profit will buy back in lower
0 · Reply
FinanceCorp
FinanceCorp Sep. 4 at 2:53 PM
$PACB we closed at $1.37 or so last week we got to regain that. The weekly chart looks beautiful the double bottom is in but we gotta break this
0 · Reply
MingLin
MingLin Sep. 4 at 2:41 PM
$PACB 👍🏽🇨🇳
1 · Reply
Razor_Ramon
Razor_Ramon Sep. 4 at 12:10 PM
$PACB Paint drying> Investing in PACB
0 · Reply
TedsRocks
TedsRocks Sep. 4 at 3:18 AM
$PACB https://www.mendelspod.com/p/doubling-down-on-long-reads-new-ceo?utm_campaign=post&utm_medium=web
0 · Reply
FinanceCorp
FinanceCorp Sep. 4 at 1:10 AM
$PACB double bottom in under 1.10. Stock will hold this level and rocket to upper $1 range
0 · Reply
Latest News on PACB
PacBio CEO Christian Henry steps down, Mark Van Oene succeeds

2026-08-05T23:35:34.000Z - 4 weeks ago

PacBio CEO Christian Henry steps down, Mark Van Oene succeeds


PacBio cuts FY26 revenue view to $155M-$165M from $165M-$175M

2026-08-05T21:31:02.000Z - 4 weeks ago

PacBio cuts FY26 revenue view to $155M-$165M from $165M-$175M


Pacific Biosciences of California Slides: Q2 2026

Aug 5, 2026, 4:30 PM EDT - 4 weeks ago

Pacific Biosciences of California Slides: Q2 2026


Pacific Biosciences of California Earnings release: Q2 2026

Aug 5, 2026, 4:30 PM EDT - 4 weeks ago

Pacific Biosciences of California Earnings release: Q2 2026


Pacific Biosciences of California Quarterly report: Q2 2026

Aug 5, 2026, 4:30 PM EDT - 4 weeks ago

Pacific Biosciences of California Quarterly report: Q2 2026


PacBio Announces Second Quarter 2026 Financial Results

Aug 5, 2026, 4:05 PM EDT - 4 weeks ago

PacBio Announces Second Quarter 2026 Financial Results


Pacific Biosciences of California Transcript: Status update

Jun 18, 2026, 11:00 AM EDT - 2 months ago

Pacific Biosciences of California Transcript: Status update


Pacific Biosciences of California Transcript: AGM 2026

Jun 3, 2026, 12:00 PM EDT - 3 months ago

Pacific Biosciences of California Transcript: AGM 2026


PacBio announces SPRQ-Nx chemistry now shipping worldwide

2026-05-26T13:35:56.000Z - 3 months ago

PacBio announces SPRQ-Nx chemistry now shipping worldwide


Pacific Biosciences of California Proxy statement: Proxy filing

May 22, 2026, 8:00 AM EDT - 3 months ago

Pacific Biosciences of California Proxy statement: Proxy filing


PacBio price target raised to $1.50 from $1 at Barclays

2026-05-11T10:14:51.000Z - 4 months ago

PacBio price target raised to $1.50 from $1 at Barclays


PacBio sees FY26 revenue $165M-$175M, consensus $174.42M

2026-05-07T22:16:25.000Z - 4 months ago

PacBio sees FY26 revenue $165M-$175M, consensus $174.42M


Pacific Biosciences of California Slides: Q1 2026

May 7, 2026, 4:30 PM EDT - 4 months ago

Pacific Biosciences of California Slides: Q1 2026


Pacific Biosciences of California Earnings release: Q1 2026

May 7, 2026, 4:30 PM EDT - 4 months ago

Pacific Biosciences of California Earnings release: Q1 2026


Pacific Biosciences of California Quarterly report: Q1 2026

May 7, 2026, 4:30 PM EDT - 4 months ago

Pacific Biosciences of California Quarterly report: Q1 2026


PacBio Announces First Quarter 2026 Financial Results

May 7, 2026, 4:05 PM EDT - 4 months ago

PacBio Announces First Quarter 2026 Financial Results


Pacific Biosciences of California Proxy statement: Proxy filing

Apr 23, 2026, 8:00 AM EDT - 4 months ago

Pacific Biosciences of California Proxy statement: Proxy filing


Pacific Biosciences of California Proxy statement: Proxy filing

Apr 23, 2026, 8:00 AM EDT - 4 months ago

Pacific Biosciences of California Proxy statement: Proxy filing


PacBio price target lowered to $1 from $1.50 at Barclays

2026-04-14T10:47:16.000Z - 4 months ago

PacBio price target lowered to $1 from $1.50 at Barclays


PacBio HiFi selected by Basecamp Research AI lab

2026-03-18T13:10:45.000Z - 5 months ago

PacBio HiFi selected by Basecamp Research AI lab


PacBio downgraded to Underweight from Equal Weight at Barclays

2026-03-06T11:31:43.000Z - 6 months ago

PacBio downgraded to Underweight from Equal Weight at Barclays


PacBio downgraded to Underweight from Equal Weight at Barclays

2026-03-06T11:11:00.000Z - 6 months ago

PacBio downgraded to Underweight from Equal Weight at Barclays


PacBio appoints Gibson to Board of Directors

2026-03-05T13:44:59.000Z - 6 months ago

PacBio appoints Gibson to Board of Directors

RXRX


PacBio files automatic mixed securities shelf

2026-02-25T22:11:20.000Z - 6 months ago

PacBio files automatic mixed securities shelf


Pacific Biosciences of California Annual report: Q4 2025

Feb 12, 2026, 5:00 PM EST - 6 months ago

Pacific Biosciences of California Annual report: Q4 2025


Pacific Biosciences of California Earnings release: Q4 2025

Feb 12, 2026, 5:00 PM EST - 6 months ago

Pacific Biosciences of California Earnings release: Q4 2025


Pacific Biosciences of California Slides: Q4 2025

Feb 12, 2026, 5:00 PM EST - 6 months ago

Pacific Biosciences of California Slides: Q4 2025


Pacific Biosciences of California Annual report: Q4 2025

Feb 12, 2026, 5:00 PM EST - 6 months ago

Pacific Biosciences of California Annual report: Q4 2025


PacBio reports Q4 EPS (12c), consensus (13c)

2026-02-12T21:18:04.000Z - 6 months ago

PacBio reports Q4 EPS (12c), consensus (13c)


PacBio announces collaboration with iHope

2026-02-12T12:23:09.000Z - 6 months ago

PacBio announces collaboration with iHope


PacBio completes sale of short-read sequencing assets

2026-02-02T14:11:41.000Z - 7 months ago

PacBio completes sale of short-read sequencing assets


PacBio Completes Sale of Short-Read Sequencing Assets

Feb 2, 2026, 9:05 AM EST - 7 months ago

PacBio Completes Sale of Short-Read Sequencing Assets


Pacific Biosciences of California Quarterly report: Q3 2025

Nov 5, 2025, 4:30 PM EST - 10 months ago

Pacific Biosciences of California Quarterly report: Q3 2025


Pacific Biosciences of California Earnings release: Q3 2025

Nov 5, 2025, 4:30 PM EST - 10 months ago

Pacific Biosciences of California Earnings release: Q3 2025


Pacific Biosciences of California Slides: Q3 2025

Nov 5, 2025, 4:30 PM EST - 10 months ago

Pacific Biosciences of California Slides: Q3 2025


Pacific Biosciences of California Quarterly report: Q2 2025

Aug 7, 2025, 5:00 PM EDT - 1 year ago

Pacific Biosciences of California Quarterly report: Q2 2025


Pacific Biosciences of California Earnings release: Q2 2025

Aug 7, 2025, 5:00 PM EDT - 1 year ago

Pacific Biosciences of California Earnings release: Q2 2025


Pacific Biosciences of California Slides: Q2 2025

Aug 7, 2025, 5:00 PM EDT - 1 year ago

Pacific Biosciences of California Slides: Q2 2025


PacBio to Present at Upcoming Investor Conferences

Aug 6, 2025, 9:00 AM EDT - 1 year ago

PacBio to Present at Upcoming Investor Conferences


Pacific Biosciences of California Transcript: AGM 2025

Jun 4, 2025, 12:00 PM EDT - 1 year ago

Pacific Biosciences of California Transcript: AGM 2025


Pacific Biosciences of California Quarterly report: Q1 2025

May 8, 2025, 4:30 PM EDT - 1 year ago

Pacific Biosciences of California Quarterly report: Q1 2025


Pacific Biosciences of California Earnings release: Q1 2025

May 8, 2025, 4:30 PM EDT - 1 year ago

Pacific Biosciences of California Earnings release: Q1 2025


Pacific Biosciences of California Slides: Q1 2025

May 8, 2025, 4:30 PM EDT - 1 year ago

Pacific Biosciences of California Slides: Q1 2025


PacBio Announces First Quarter 2025 Financial Results

May 8, 2025, 4:15 PM EDT - 1 year ago

PacBio Announces First Quarter 2025 Financial Results


PacBio Grants Equity Incentive Award to New Employee

Apr 4, 2025, 7:45 PM EDT - 1 year ago

PacBio Grants Equity Incentive Award to New Employee


Pacific Biosciences Names Jim Gibson Chief Financial Officer

Mar 27, 2025, 9:22 AM EDT - 1 year ago

Pacific Biosciences Names Jim Gibson Chief Financial Officer


Jim Gibson to join PacBio as Chief Financial Officer

Mar 27, 2025, 9:05 AM EDT - 1 year ago

Jim Gibson to join PacBio as Chief Financial Officer


janed102
janed102 Sep. 5 at 11:49 PM
$PACB Weekend reading for you... https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2026.1861975/full
0 · Reply
FinanceCorp
FinanceCorp Sep. 4 at 8:19 PM
$PACB closed out my near term trade from this week , kept a fairly large position in place
1 · Reply
FinanceCorp
FinanceCorp Sep. 4 at 8:03 PM
$PACB took profit . We closed at 1.40 last week . To close five cents under that for a penny trade is a lot, if it would’ve regained that 1.40 range then we were good to go. The volume is just way too low . Possible further downside and a break of support levels at 1.28
0 · Reply
FinanceCorp
FinanceCorp Sep. 4 at 7:53 PM
$PACB give me 1.37 and I’ll relax , if not have to take profit
0 · Reply
selftaught
selftaught Sep. 4 at 3:33 PM
$PACB out for a quick profit will buy back in lower
0 · Reply
FinanceCorp
FinanceCorp Sep. 4 at 2:53 PM
$PACB we closed at $1.37 or so last week we got to regain that. The weekly chart looks beautiful the double bottom is in but we gotta break this
0 · Reply
MingLin
MingLin Sep. 4 at 2:41 PM
$PACB 👍🏽🇨🇳
1 · Reply
Razor_Ramon
Razor_Ramon Sep. 4 at 12:10 PM
$PACB Paint drying> Investing in PACB
0 · Reply
TedsRocks
TedsRocks Sep. 4 at 3:18 AM
$PACB https://www.mendelspod.com/p/doubling-down-on-long-reads-new-ceo?utm_campaign=post&utm_medium=web
0 · Reply
FinanceCorp
FinanceCorp Sep. 4 at 1:10 AM
$PACB double bottom in under 1.10. Stock will hold this level and rocket to upper $1 range
0 · Reply
FinanceCorp
FinanceCorp Sep. 3 at 8:23 PM
$PACB seems to me like the bio pharmaceutical space needs some news to get it going
0 · Reply
FinanceCorp
FinanceCorp Sep. 3 at 5:05 PM
$PACB I despise consolidation0 periods . Although it’s a great technical to watch, some last for years as this one has. On a short term basis when you look at this consolidation that just occurred here at the low $1.30 range, should see a strong bounce into the end of the week that breaks that 1.60 range
0 · Reply
selftaught
selftaught Sep. 3 at 3:00 PM
$PACB in at 1.29 at the moment
0 · Reply
MrScottTwits
MrScottTwits Sep. 3 at 5:46 AM
$PACB AI capacity is now available and diversification into this space is wise.
0 · Reply
FinanceCorp
FinanceCorp Sep. 2 at 7:59 PM
$PACB man do I wish the institutions would just take this one out of this range for good to the upside, I don’t know why they let these penny traders do what they do best
0 · Reply
FinanceCorp
FinanceCorp Sep. 2 at 3:57 PM
$PACB now the consolidation period begins
0 · Reply
selftaught
selftaught Sep. 2 at 3:48 PM
$PACB Give me 1.27!
1 · Reply
selftaught
selftaught Sep. 2 at 3:22 PM
$PACB I feel like we will have a final push down today before we see the recovery.
0 · Reply
DomLuminous
DomLuminous Sep. 2 at 3:10 PM
$PACB the name is so bad its good, TWST had a monster run....looking for this to have a similar run.
0 · Reply
FinanceCorp
FinanceCorp Sep. 1 at 9:49 PM
$PACB we bounce mañana
0 · Reply
TedsRocks
TedsRocks Sep. 1 at 8:23 PM
$PACB The goal of the NIH-led Bio Genesis Mission is to double the pace of biomedical innovation, from discovery to health impact, within the next five to 10 years. The Bio Genesis Mission, NIH's contribution to that national effort, represents a major initiative to accelerate biomedical discovery and improve health outcomes by leveraging artificial intelligence, advanced computing, innovative approaches to policy and governance, and public-private partnerships. This is more than applying AI to existing research workflows. It is about reimagining how researchers, institutions, data resources, and scientific infrastructure work together to solve the biomedical challenges that matter most to American patients and families, while safeguarding the sensitive data that makes this research possible. This is an opportunity for PacBio. They’ve already shown succes with Google when utilizing AI on the WGS data.
0 · Reply
TedsRocks
TedsRocks Sep. 1 at 8:19 PM
$PACB https://www.pacb.com/blog/improving-hifi-sequencing-accuracy-with-google-deepconsensus-and-alphaevolve/
0 · Reply